Hepatitis Treatment News
A Smart + Strong Site
Subscribe to:
Hep Magazine In Bulk
Hep Newsletter
Join Us:

Back to home » Hepatitis Treatment News


June 29, 2015
Injection Drug Users Have Low Risk of Hep C Reinfection
Compared with injection drug users’ overall risk of hepatitis C, those IDUs who have been infected and cured have a relatively low risk of reinfection.
June 24, 2015
Hep C Worsens Progression of Hep B Disease
Those with hepatitis B experience greater liver disease progression if they are coinfected with hepatitis C, while HBV does not appear to worsen the effects of HCV.
June 22, 2015
Mixed Results for GlobeImmune’s Hepatitis B Drug
GlobeImmune’s investigational hepatitis B treatment, GS-4774, had mixed results in a Phase II trial.
June 15, 2015
Treating Hep C Halves New Cases Among UK Gay Men
Scaling up treatment of hepatitis C among gay and bisexual men in the United Kingdom could in half the number of new cases among that population.
June 10, 2015
Harvoni and Sovaldi/Daclatasvir Safer to Mix With HIV Meds
Harvoni and the combination of Sovaldi and daclatasvir were the least likely to cause a severe reaction with the HIV regimens of a cohort of HIV/hepatitis C coinfected adults.
June 08, 2015
Hepatitis C Viral Network Cooperates to Dodge Immune System
The population of hepatitis C within the body is interconnected rather like an online social network and cooperates to evade the immune system.
June 03, 2015
8 Weeks of Daclatasvir/Sovaldi Cures Some With HCV/HIV
Eight weeks of daclatasvir and Sovaldi cured hepatitis C in 76 percent of people coinfected with HIV in a recent trial, including all of those with low hep C viral loads at the outset.
June 01, 2015
Merck Seeks FDA Approval of Hep C Tablet Grazoprevir/Elbasvir
Merck has filed a new drug application with the U.S. Food and Drug Administration (FDA) for approval of its single-tablet hepatitis C treatment.
Archives
   

June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
January 2008


QUICK LINKS

Current Issue
Forums
Poll
Blogs
Hep Stories
Calendar
Services Directory
Conference News
Top Stories
Treatment News
Hep Exclusives
All About Hepatitis
• Hepatitis A
Transmission
Prevention
Treatment
• Hepatitis B
Transmission
Prevention
Treatment
• Hepatitis C
Transmission
Prevention
Treatment
HCV/HIV Coinfection
Help Paying For Meds
Clinical Trials
TALK TO US
Tell us what you think
Poll
Do you have difficulties traveling with hepatitis C?
Yes
No


Survey
Hepatitis C Reader Survey
HEP ON TWITTER
© 2015 Smart + Strong. All Rights Reserved. Terms of use and Your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.